The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer

Table 1 The General Data of the Trial and Control Group

Item		Trial group (n = 69)	Control group (n = 36)	P
Sex				0.362
Male		50	29
Female		19	7
Median age (year)		52	51	0.437
Type of tumors				0.638*
NSCLC		17	6
Gastric cancer		32	18
Colorectal cancer		20	12
KPS ()		85.31 ± 6.07	86.69 ± 7.81	0.334
Clinical stage				0.630
III		11	8
IV		58	28
NSCLC	III	5	3	0.621*
	IV	12	3
Gastric cancer	III	4	3	0.684
	IV	28	15
Colorectal cancer	III	2	2	0.620*
	IV	18	10

*The p value is calculated by Fisher exact chi-square because n < 30 or some cells have expected count less than 1.

ISSN: 1479-5876